ATE140972T1 - Fusionsproteine bestehend aus tratp und mindestens einem lhrh-analog - Google Patents

Fusionsproteine bestehend aus tratp und mindestens einem lhrh-analog

Info

Publication number
ATE140972T1
ATE140972T1 AT90912564T AT90912564T ATE140972T1 AT E140972 T1 ATE140972 T1 AT E140972T1 AT 90912564 T AT90912564 T AT 90912564T AT 90912564 T AT90912564 T AT 90912564T AT E140972 T1 ATE140972 T1 AT E140972T1
Authority
AT
Austria
Prior art keywords
fusion proteins
tratp
pct
proteins consisting
lhrh analog
Prior art date
Application number
AT90912564T
Other languages
English (en)
Inventor
Gregory John Russell-Jones
Andrew George Stewart
Con George Tsonis
Original Assignee
Biotech Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Australia Pty Ltd filed Critical Biotech Australia Pty Ltd
Application granted granted Critical
Publication of ATE140972T1 publication Critical patent/ATE140972T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/811Drug, bio-affecting and body treating compositions involving sex selection or contraception
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/13Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
AT90912564T 1989-08-25 1990-08-24 Fusionsproteine bestehend aus tratp und mindestens einem lhrh-analog ATE140972T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPJ597989 1989-08-25

Publications (1)

Publication Number Publication Date
ATE140972T1 true ATE140972T1 (de) 1996-08-15

Family

ID=3774139

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90912564T ATE140972T1 (de) 1989-08-25 1990-08-24 Fusionsproteine bestehend aus tratp und mindestens einem lhrh-analog

Country Status (7)

Country Link
US (1) US5403586A (de)
EP (1) EP0446313B1 (de)
AT (1) ATE140972T1 (de)
CA (1) CA2040441C (de)
DE (1) DE69027983T2 (de)
NZ (1) NZ235038A (de)
WO (1) WO1991002799A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484592A (en) * 1989-03-23 1996-01-16 Stitching Centraal Diergeneeskundig Instituut Peptide, immunogenic composition and vaccine or medicinal preparation: a method of immunising a mammal against LHRH, and a method of improving the meat quality of pigs
US5500366A (en) * 1990-09-18 1996-03-19 Biotech Australia Pty. Ltd. Polynucleotide encoding T-cell epitopes of the protein TraT
US5837268A (en) 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
US5723129A (en) * 1991-10-16 1998-03-03 University Of Saskatchewan GnRH-leukotoxin chimeras
CA2123580C (en) * 1992-09-16 2005-04-26 James B. Dale Antigen of hybrid m protein and carrier for group a streptococcal vaccine
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
AUPO776897A0 (en) * 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
AUPP807399A0 (en) * 1999-01-08 1999-02-04 Csl Limited Improved immunogenic lhrh composition and methods relating thereto
PT1035133E (pt) * 1999-02-17 2005-05-31 Pfizer Prod Inc Proteinas de fusao compreendendo veiculos que podem induzir uma dupla resposta imune
US6838553B1 (en) * 1999-10-05 2005-01-04 Academia Sinica Peptide repeat immunogens
US6783761B2 (en) 2000-05-05 2004-08-31 Aphton Corporation Chimeric peptide immunogens
CA2736604C (en) 2008-09-17 2017-01-03 Charles Rupprecht Rabies virus-based recombinant immunocontraceptive compositions and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4624926A (en) * 1981-01-02 1986-11-25 The Research Foundation Of State University Of New York Novel cloning vehicles for polypeptide expression in microbial hosts
DK582381A (da) * 1981-01-02 1982-07-03 Univ New York Remkombinat plasmid til anvendelse ved bakteriel kloning
AU619443B2 (en) * 1986-04-21 1992-01-30 Bioenterprises Pty. Ltd. Immunopotentiation
CA1331355C (en) * 1986-04-21 1994-08-09 Bioenterprises Pty. Ltd Immunopotentation
NZ220932A (en) * 1986-07-03 1990-05-28 Victoria State Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
AU7642387A (en) * 1986-07-03 1988-01-29 State Of Victoria, The Composition and method for immunological castration and spaying
AU602187B2 (en) * 1987-01-14 1990-10-04 Commonwealth Scientific And Industrial Research Organisation Anti-reproductive hormone
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones

Also Published As

Publication number Publication date
DE69027983D1 (de) 1996-09-05
DE69027983T2 (de) 1997-03-20
NZ235038A (en) 1992-09-25
CA2040441C (en) 1998-03-31
EP0446313B1 (de) 1996-07-31
WO1991002799A1 (en) 1991-03-07
EP0446313A4 (en) 1992-08-19
US5403586A (en) 1995-04-04
CA2040441A1 (en) 1991-02-26
EP0446313A1 (de) 1991-09-18

Similar Documents

Publication Publication Date Title
ATE140972T1 (de) Fusionsproteine bestehend aus tratp und mindestens einem lhrh-analog
AU655915B2 (en) Cosmetic deodorants
DE69334266D1 (de) Therapeutische Zusammensetzungen aus Antikorper und Antisens Nukleinsäuren gegen Serrate
DK1378572T3 (da) BMP-11-sammensætninger
DE69331520D1 (de) Verwendung von bacillus thuringiensis-isolaten zur kontrolle von schädlingen aus der familie aphididae
NO892033D0 (no) Fibronectinbindende protein.
DE69331501D1 (de) Unterdrückung der Proliferation von T-Zellen mittels Peptidfragmenten des basischen Proteins aus Myelin
NO882380L (no) Fibfonektin-bindende protein, samt fremstilling derav.
ATE69727T1 (de) Zusammensetzung zur behandlung von an haemophilia- a-inhibitor leidenden kranken.
AU6070390A (en) Compositions derived from bi4v2o11
DK0914419T3 (da) Transgene mus i stand til at udtrykke leukæmiinhiberende faktor
ATE107859T1 (de) Verwendung von antiprogestomimetika zur stimulierung des eisprungs.
DE69607034D1 (de) Pcna bindende substanz
ATE155008T1 (de) Neue bacillus-thuringiensis isolate zur bekämpfung von akariden
DE59206628D1 (en) Expression signalpeptid-freier staphylokinasen
SE8801723D0 (sv) Fibronectin binding protein as well as its preparation
ATE148744T1 (de) Neue thrombininhibitorische proteine aus landblutegeln
ES2059801T3 (es) Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.
GB2283974A (en) Allatostatins and their use
IL97885A0 (en) Growth hormone releasing factor analogs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties